Recursion announced the appointment of Dr. Ramona Doyle as its Chief Medical Officer. Dr. Doyle will lead Recursion’s pipeline through clinical development programs, including its four assets progressing towards Phase 2 trials. Before joining Recursion, Dr. Doyle most recently served as the Chief Medical Officer at Blade Therapeutics. She has 12-plus years of experience in drug development, working in increasing roles of importance at Gilead Sciences, Genentech and Roche before serving as Vice President of the California Institute of Regenerative Medicine, a funding agency for advanced stem cell-based therapies.